Immunologic Basis of Anti-IgE Therapy (Study II: On Patients With Asthma) (Xolair)
This study has been completed.
Sponsor:
University of California, Davis
Information provided by:
University of California, Davis
ClinicalTrials.gov Identifier:
NCT00367016
First received: August 19, 2006
Last updated: May 25, 2011
Last verified: May 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | December 2008 |
| Primary Completion Date: | August 2008 (Final data collection date for primary outcome measure) |